{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T11:54:34Z","timestamp":1782647674142,"version":"3.54.5"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T00:00:00Z","timestamp":1726444800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100008397","name":"Velux Fonden","doi-asserted-by":"publisher","award":["00041038"],"award-info":[{"award-number":["00041038"]}],"id":[{"id":"10.13039\/100008397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ophthalmol Ther"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s40123-024-01028-4","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T19:02:34Z","timestamp":1726513354000},"page":"3035-3046","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The I-OPTA Questionnaire: A National Assessment of Patients with Neovascular Age-Related Macular Degeneration"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3450-3568","authenticated-orcid":false,"given":"Benjamin Sommer","family":"Thinggaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasper","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freja","family":"Dinesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Kj\u00f8ller","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Mors\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousif","family":"Subhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Grauslund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonny","family":"Stokholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,9,16]]},"reference":[{"issue":"10153","key":"1028_CR1","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/S0140-6736(18)31550-2","volume":"392","author":"P Mitchell","year":"2018","unstructured":"Mitchell P, Liew G, Gopinath B, Wong TY. Age-related macular degeneration. Lancet. 2018;392(10153):1147\u201359.","journal-title":"Lancet"},{"key":"1028_CR2","doi-asserted-by":"publisher","unstructured":"Thinggaard BS, Subhi Y, Ismail FA, Pedersen M, Mors\u00f8 L, Grauslund J, Stokholm L. Factors affecting quality of life in patients with neovascular age-related macular degeneration. AJO Int. 1(3):100066. https:\/\/doi.org\/10.1016\/j.ajoint.2024.100066","DOI":"10.1016\/j.ajoint.2024.100066"},{"issue":"1","key":"1028_CR3","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1111\/aos.15201","volume":"101","author":"RP Gale","year":"2023","unstructured":"Gale RP, Finger RP, Eldem B, Aslam T, Barratt J, Daien V, et al. The management of neovascular age-related macular degeneration: a systematic literature review of patient-reported outcomes, patient mental health and caregiver burden. Acta Ophthalmol. 2023;101(1):e26\u201342.","journal-title":"Acta Ophthalmol"},{"issue":"13","key":"1028_CR4","doi-asserted-by":"publisher","first-page":"2736","DOI":"10.1038\/s41433-023-02407-0","volume":"37","author":"KV Vu","year":"2023","unstructured":"Vu KV, Mitchell P, Detaram HD, Burlutsky G, Liew G, Gopinath B. Risk factors for poorer quality of life in patients with neovascular age-related macular degeneration: a longitudinal clinic-based study. Eye (London). 2023;37(13):2736\u201343.","journal-title":"Eye (London)"},{"key":"1028_CR5","doi-asserted-by":"crossref","unstructured":"Thinggaard BS, Pedersen F, Grauslund J, Stokholm L. Intravitreal vascular endothelial growth factor inhibitor therapy in Denmark and 5-Year projections. JAMA Netw Open. 2023;6(9):e2335148.","DOI":"10.1001\/jamanetworkopen.2023.35148"},{"key":"1028_CR6","doi-asserted-by":"crossref","unstructured":"Frederiksen KH, Stokholm L, M\u00f6ller S, Thinggaard BS, Kawasaki R, Peto T, et al. VEGF inhibition in retinal vein occlusion does not associate with cardiovascular morbidity or mortality. Ophthalmol Retina. 2023;7(8):652\u201360.","DOI":"10.1016\/j.oret.2023.02.009"},{"issue":"3","key":"1028_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2023.100446","volume":"4","author":"BS Thinggaard","year":"2024","unstructured":"Thinggaard BS, Frederiksen K, Subhi Y, M\u00f6ller S, S\u00f8rensen TL, Kawasaki R, et al. VEGF inhibition associates with decreased risk of mortality in patients with neovascular age-related macular degeneration. Ophthalmol Sci. 2024;4(3): 100446.","journal-title":"Ophthalmol Sci"},{"key":"1028_CR8","doi-asserted-by":"publisher","first-page":"7194927","DOI":"10.1155\/2017\/7194927","volume":"2017","author":"Y Subhi","year":"2017","unstructured":"Subhi Y, S\u00f8rensen TL. Neovascular age-related macular degeneration in the very old (\u2265 90 years): epidemiology, adherence to treatment, and comparison of efficacy. J Ophthalmol. 2017;2017:7194927.","journal-title":"J Ophthalmol"},{"issue":"11","key":"1028_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-077175","volume":"13","author":"BS Thinggaard","year":"2023","unstructured":"Thinggaard BS, Pedersen M, Sorensen TL, Grauslund J, Stokholm L. Patient perspectives and barriers in the treatment of neovascular age-related macular degeneration in Denmark: a qualitative study. BMJ Open. 2023;13(11): e077175.","journal-title":"BMJ Open"},{"issue":"1","key":"1028_CR10","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1186\/s12886-022-02602-9","volume":"22","author":"CN Fonteh","year":"2022","unstructured":"Fonteh CN, Mathias MT, Mandava N, Manoharan N, Lynch AM, Navo R, et al. Mental health and visual acuity in patients with age-related macular degeneration. BMC Ophthalmol. 2022;22(1):391.","journal-title":"BMC Ophthalmol"},{"issue":"6","key":"1028_CR11","first-page":"A4290","volume":"58","author":"MS S\u00f8rensen","year":"2011","unstructured":"S\u00f8rensen MS, Andersen S, Henningsen GO, Larsen CT, S\u00f8rensen TL. Danish version of Visual Function Questionnaire-25 and its use in age-related macular degeneration. Dan Med Bull. 2011;58(6):A4290.","journal-title":"Dan Med Bull"},{"issue":"5","key":"1028_CR12","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/jamaophthalmol.2021.0146","volume":"139","author":"L Assi","year":"2021","unstructured":"Assi L, Chamseddine F, Ibrahim P, Sabbagh H, Rosman L, Congdon N, et al. A global assessment of eye health and quality of life: a systematic review of systematic reviews. JAMA Ophthalmol. 2021;139(5):526\u201341.","journal-title":"JAMA Ophthalmol"},{"key":"1028_CR13","doi-asserted-by":"publisher","first-page":"233372141880160","DOI":"10.1177\/2333721418801601","volume":"4","author":"AC Schippert","year":"2018","unstructured":"Schippert AC, Jelin E, Moe MC, Heiberg T, Grov EK. The impact of age-related macular degeneration on quality of life and its association with demographic data: results from the NEI VFQ-25 questionnaire in a Norwegian population. Gerontol Geriatr Med. 2018;4:2333721418801601.","journal-title":"Gerontol Geriatr Med"},{"issue":"1","key":"1028_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1186\/s12955-017-0732-7","volume":"15","author":"S Nickels","year":"2017","unstructured":"Nickels S, Schuster AK, Singer S, Wild PS, Laubert-Reh D, Schulz A, et al. The National Eye Institute 25-Item Visual Function Questionnaire (NEI VFQ-25)\u2014reference data from the German population-based Gutenberg Health Study (GHS). Health Qual Life Outcomes. 2017;15(1):156.","journal-title":"Health Qual Life Outcomes"},{"key":"1028_CR15","unstructured":"Subhi Y, Munch IC, Singh A, S\u00f8rensen TL. Physical activity benefits patients with age-related macular degeneration. Ugeskr Laeger. 2014;176(37):V12130712."},{"key":"1028_CR16","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/895147","volume":"2013","author":"S Velilla","year":"2013","unstructured":"Velilla S, Garc\u00eda-Medina JJ, Garc\u00eda-Layana A, Dolz-Marco R, Pons-V\u00e1zquez S, Pinazo-Dur\u00e1n MD, et al. Smoking and age-related macular degeneration: review and update. J Ophthalmol. 2013;2013: 895147.","journal-title":"J Ophthalmol"},{"issue":"8","key":"1028_CR17","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1016\/j.ophtha.2013.01.021","volume":"120","author":"EY Chew","year":"2013","unstructured":"Chew EY, Clemons TE, Agr\u00f3n E, Sperduto RD, Sangiovanni JP, Kurinij N, et al. Long-term effects of vitamins C and E, \u03b2-carotene, and zinc on age-related macular degeneration: AREDS report no. 35. Ophthalmology. 2013;120(8):1604-11.e4.","journal-title":"Ophthalmology"},{"issue":"2","key":"1028_CR18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1001\/archopht.116.2.227","volume":"116","author":"CM Mangione","year":"1998","unstructured":"Mangione CM, Berry S, Spritzer K, Janz NK, Klein R, Owsley C, et al. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch Ophthalmol. 1998;116(2):227\u201333.","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"1028_CR19","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1001\/archopht.119.7.1050","volume":"119","author":"CM Mangione","year":"2001","unstructured":"Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119(7):1050\u20138.","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"1028_CR20","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1167\/iovs.10-5645","volume":"52","author":"P Orr","year":"2011","unstructured":"Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, et al. Validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) in age-related macular degeneration. Investig Ophthalmol Vis Sci. 2011;52(6):3354\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"2","key":"1028_CR21","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1167\/iovs.09-3766","volume":"51","author":"DA Revicki","year":"2010","unstructured":"Revicki DA, Rentz AM, Harnam N, Thomas VS, Lanzetta P. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration. Investig Ophthalmol Vis Sci. 2010;51(2):712\u20137.","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"1","key":"1028_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1477-7525-3-25","volume":"3","author":"J Mitchell","year":"2005","unstructured":"Mitchell J, Wolffsohn JS, Woodcock A, Anderson SJ, McMillan CV, Ffytche T, et al. Psychometric evaluation of the MacDQoL individualised measure of the impact of macular degeneration on quality of life. Health Qual Life Outcomes. 2005;3(1):25.","journal-title":"Health Qual Life Outcomes"},{"key":"1028_CR23","unstructured":"Institute M. https:\/\/www.mapi-institute.com\/linguistic-validation\/methodology. Accessed 30 July 2024."},{"key":"1028_CR24","unstructured":"Borger.dk. Fritagelse fra Digital Post 2024. https:\/\/www.borger.dk\/hjaelp-og-vejledning\/hvad-har-du-brug-for-hjaelp-til\/digital-post\/fritagelse-fra-digital-post. Accessed 30 July 2024."},{"issue":"2","key":"1028_CR25","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"1","key":"1028_CR26","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1186\/s13104-019-4724-z","volume":"12","author":"J Arnetz","year":"2019","unstructured":"Arnetz J, Sudan S, Goetz C, Arnetz B, Gowland L, Manji S, et al. Preliminary development of a questionnaire measuring patient views of participation in clinical trials. BMC Res Notes. 2019;12(1):667.","journal-title":"BMC Res Notes"},{"issue":"1","key":"1028_CR27","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1097\/SLA.0000000000004078","volume":"275","author":"VM Meyer","year":"2022","unstructured":"Meyer VM, Benjamens S, Moumni ME, Lange JFM, Pol RA. Global overview of response rates in patient and health care professional surveys in surgery: a systematic review. Ann Surg. 2022;275(1):e75\u201381.","journal-title":"Ann Surg"},{"issue":"8","key":"1028_CR28","doi-asserted-by":"publisher","first-page":"e341","DOI":"10.1016\/S1470-2045(14)70113-5","volume":"15","author":"LA Fern","year":"2014","unstructured":"Fern LA, Lewandowski JA, Coxon KM, Whelan J. Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials. Lancet Oncol. 2014;15(8):e341\u201350.","journal-title":"Lancet Oncol"},{"issue":"6","key":"1028_CR29","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1089\/cyber.2009.0445","volume":"13","author":"M Hoerger","year":"2010","unstructured":"Hoerger M. Participant dropout as a function of survey length in internet-mediated university studies: implications for study design and voluntary participation in psychological research. Cyberpsychol Behav Soc Netw. 2010;13(6):697\u2013700.","journal-title":"Cyberpsychol Behav Soc Netw"},{"issue":"3","key":"1028_CR30","first-page":"Cd005139","volume":"3","author":"SD Solomon","year":"2019","unstructured":"Solomon SD, Lindsley K, Vedula SS, Krzystolik MG, Hawkins BS. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration. Cochrane Database Syst Rev. 2019;3(3):Cd005139.","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"1028_CR31","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1186\/s12886-020-01554-2","volume":"20","author":"RP Finger","year":"2020","unstructured":"Finger RP, Daien V, Eldem BM, Talks JS, Korobelnik JF, Mitchell P, et al. Anti-vascular endothelial growth factor in neovascular age-related macular degeneration\u2014a systematic review of the impact of anti-VEGF on patient outcomes and healthcare systems. BMC Ophthalmol. 2020;20(1):294.","journal-title":"BMC Ophthalmol"},{"issue":"1","key":"1028_CR32","doi-asserted-by":"publisher","DOI":"10.1136\/bmjophth-2019-000353","volume":"4","author":"E Jelin","year":"2019","unstructured":"Jelin E, Wisl\u00f8ff T, J\u00f8rstad \u00d8K, Heiberg T, Moe MC. Patient-reported outcome measures in the management of neovascular age-related macular degeneration: a 1-year prospective study. BMJ Open Ophthalmol. 2019;4(1): e000353.","journal-title":"BMJ Open Ophthalmol"},{"issue":"1","key":"1028_CR33","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s41687-024-00775-z","volume":"8","author":"AM Kubin","year":"2024","unstructured":"Kubin AM, Korva-Gurung I, Ohtonen P, Hautala N. Health-related quality of life in patients with neovascular age-related macular degeneration: a prospective cohort study. J Patient Rep Outcomes. 2024;8(1):89.","journal-title":"J Patient Rep Outcomes"}],"updated-by":[{"DOI":"10.1007\/s40123-024-01063-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T00:00:00Z","timestamp":1730678400000}}],"container-title":["Ophthalmology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01028-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40123-024-01028-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40123-024-01028-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T13:13:30Z","timestamp":1731590010000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40123-024-01028-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,16]]},"references-count":33,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["1028"],"URL":"https:\/\/doi.org\/10.1007\/s40123-024-01028-4","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s40123-024-01063-1","asserted-by":"object"}]},"ISSN":["2193-8245","2193-6528"],"issn-type":[{"value":"2193-8245","type":"print"},{"value":"2193-6528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,16]]},"assertion":[{"value":"31 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 August 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2024","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised to correct the last sentence in discussion section and to correct the supplementary information file.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2024","order":7,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":8,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":9,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s40123-024-01063-1","URL":"https:\/\/doi.org\/10.1007\/s40123-024-01063-1","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Benjamin Sommer Thinggaard has received speaker\u2019s fee from Roche. Yousif Subhi have received speaker\u2019s fee from Bayer and Roche, and have served as an advisory board member for Apellis, not related to this work. Yousif Subhi is an Editorial Board member of <i>Ophthalmology and Therapy<\/i>, however, was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Jakob Grauslund declares to have received speaker\u2019s fee from Allergan, Bayer, Novartis, and Roche, and to have served as an advisory board member for Allergan, Apellis, Bayer, Novartis, and Roche, not related to this work. The authors confirm that only they have contributed to the study, and none of the companies were involved in the research, analysis, or writing of this manuscript. Kasper Hansen, Freja Dinesen, Maria Kj\u00f8ller\u00a0Pedersen, Lars Mors\u00f8, and Lonny Stokholm declare that no potential conflicts of interest exist in relation to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The study adhered to the ethical principles outlined in the Declaration of Helsinki. Prior to participating in the study, all participants provided written informed consent. Confidentiality of the participants' data was strictly maintained, following established guidelines for data handling and protection. The study was assigned the record number 22\/10138 in the register of the Region of Southern Denmark, indicating its official registration. Although the study was reviewed by The Regional Committees on Health Research Ethics for Southern Denmark, it did not require explicit permission to be conducted.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}